Tetanus News and Research

RSS

Tetanus is a severe, frequently fatal disease caused by an exotoxin produced by Clostridium tetani, a bacterium that is found in the environment. Tetanus is not transmitted from person to person. Rather, Clostridium tetani enters the body through an open wound, including lacerations, abrasions and puncture wounds. The toxin causes neuromuscular dysfunction, with rigidity and spasms of skeletal muscles. The muscle spasms usually start in the jaw (which is why the disease is sometimes called "lockjaw") and neck and may spread to many other muscles, leading to generalized paralysis.

3 million newborn babies' lives could be saved for less than $1 per child

3 million newborn babies' lives could be saved for less than $1 per child, with interventions such as tetanus immunization during pregnancy, exclusive breastfeeding, clean delivery and antibiotics to treat illness.

4 Mar 2005

Medical interventions during pregnancy and childbirth may not be the best way to improve newborn survival

In Brazil neonatal mortality declined in the 1980’s but rates have virtually remained unchanged since the 1990’s. Fernando Barros (Hospital de Clinicas, Montevideo, Uruguay) and colleagues studied births in 1992, 1993, and 2004 in the Brazilian city of Pelotas. They found that important changes in maternal characteristics occurred over the 22 years covered by the study.

3 Mar 2005

Lancet neonatal survival series

Three million of the four million newborn babies who die worldwide each year could be saved by low-tech and low-cost interventions, concludes a landmark series of articles published online by The Lancet (Thursday March 3, 2005).

3 Mar 2005

Fear of botulism as a bioterrorist weapon is to be reduced by British vaccine technology

Fear of botulism as a bioterrorist weapon is to be reduced, as the US government announces its support for a new British vaccine technology, which promises for the first time to provide an effective defence against botulism – the most deadly naturally occurring substance.

28 Feb 2005

Findings could lead to new knowledge that could speed the development of drugs to block botulism or tetanus toxins more rapidly

The first detailed structure of a botulism toxin attached to its target protein reveals that the toxin snakes the protein around itself — a sort of “reverse anaconda” — to recognize the receptor.

13 Dec 2004

New technologies boost immunisation rates, safety

As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.

6 Dec 2004

Animal research and its benefits to both humans and animals

From preventing polio to finding cures for cancer patients, animal research has saved countless lives.

18 Nov 2004

Vaccine contributions to health highlighted at PAHO meeting

Vaccine programs in the Americas have made major contributions to improving health in the Americas and new vaccines could go even further, said Dr. D.A. Henderson, a global expert who chairs a Pan American Health Organization (PAHO) technical group here today.

4 Nov 2004

$73 million to tackle infectious diseases such as West Nile virus and influenza

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 14 contracts totaling more than $73 million to fund the Large-Scale Antibody and T Cell Epitope Discovery Program, an initiative aimed at quickly identifying the regions of selected infectious agents that elicit immune reactions.

1 Nov 2004

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

A UK vaccine technology that is set to revolutionise the industry has received £950k funding from the Department for International Development (DFID) to bring to production a pentavalent childhood vaccine that can be stored without refrigeration.

25 Oct 2004

Infections among injecting drug users are a growing public health concern in the UK

New figures published by the UK's Health Protection Agency show that infections among injecting drug users (IDUs) are a growing public health concern.

13 Oct 2004

Increase in cases of pertussis (whooping cough) in Indiana

Pertussis is a contagious illness caused by bacteria. It occurs in infants and young children more often than older children and adults. Adults with milder, undiagnosed symptoms can transmit the disease to infants and children.

20 Sep 2004

German researchers are identifying lymphoma risks

Little is known about the causes of lymphoma. A case-control study conducted by Professor Nikolaus Becker and Dr. Alexandra Nieters, Division of Clinical Epidemiology at the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ), is looking closely at possible risk factors.

14 Sep 2004

ID Biomedical to supply meningitis C vaccine to the Canadian government

The Canadian government has retained an option to purchase additional product from the Company in the third and final year of the contract. The total value of the contract, including the third year option, could total approximately $30 million to ID Biomedical.

14 Sep 2004

No discernible link between the three-in-one vaccine and child behavioural problems

A new study of children’s behaviour problems has come to the conclusion that there is no discernible link with the three-in-one vaccine now being phased out in the UK.

8 Sep 2004

Drug company fights to keep toxin in vaccines

The UK announced Saturday they will remove the mercury preservative Thimerosal from their vaccines. The news comes days after an LA Times article reported that Aventis-Pasteur, a pharmaceutical giant, is pushing to keep the toxin in U.S. vaccines.

13 Aug 2004

Changes to the UK's childhood vaccination programme

From the end of September these vaccines will be given in the routine vaccination schedule in a combined vaccine along with Diphtheria, Tetanus, and Hib.

9 Aug 2004

The British government has announced plans for a new combined vaccination for babies and children

The British government has announced plans for a new combined vaccination for babies and children. A single jab will protect children against diphtheria, tetanus, pertussis (whooping cough), Haemophilus influenzae type B (Hib), and polio.

9 Aug 2004

America's childhood immunization rates are at record high levels

The U. S. Department of Health and Human Services has announced that the nation's childhood immunization rates are at record high levels, including significant increases in rates of immunization for chickenpox and pneumococcal pneumonia, the two most recent additions to the childhood immunization schedule.

2 Aug 2004

Tetanus protection requires booster shots every 10 years, starting in adolescence

As the final weeks of summer dwindle away, parents are scurrying to provide their kids with all the books, supplies and sports equipment needed to meet this year's upcoming academic and athletic challenges.

29 Jul 2004